Mitsui Dirección

Dirección controles de criterios 2/4

El CEO de Mitsui's es Kenichi Hori , nombrado en Apr 2021, tiene una permanencia de 5.83 años. compensación anual total es ¥668.00M, compuesta por 19.6% salario y 80.4% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.008% de las acciones de la empresa, por valor de €5.19M. La antigüedad media del equipo directivo y de la junta directiva es de 3 años y 2.8 años, respectivamente.

Información clave

Kenichi Hori

Chief Executive Officer (CEO)

JP¥668.0m

Compensación total

Porcentaje del salario del CEO	19.6%
Permanencia del CEO	3.1yrs
Participación del CEO	0.008%
Permanencia media de la dirección	3.1yrs
Promedio de permanencia en la Junta Directiva	2.9yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Kenichi Hori en comparación con los beneficios de Mitsui?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	JP¥1t
Dec 31 2023	n/a	n/a	JP¥1t
Sep 30 2023	n/a	n/a	JP¥1t
Jun 30 2023	n/a	n/a	JP¥1t
Mar 31 2023	JP¥668m	JP¥131m	JP¥1t
Dec 31 2022	n/a	n/a	JP¥1t
Sep 30 2022	n/a	n/a	JP¥1t
Jun 30 2022	n/a	n/a	JP¥998b
Mar 31 2022	JP¥338m	JP¥131m	JP¥915b
Dec 31 2021	n/a	n/a	JP¥770b
Sep 30 2021	n/a	n/a	JP¥630b
Jun 30 2021	n/a	n/a	JP¥464b
Mar 31 2021	JP¥128m	JP¥62m	JP¥335b
Dec 31 2020	n/a	n/a	JP¥255b
Sep 30 2020	n/a	n/a	JP¥267b
Jun 30 2020	n/a	n/a	JP¥329b
Mar 31 2020	JP¥129m	JP¥62m	JP¥392b

Compensación vs. Mercado: La compensación total ($USD4.29M) de Kenichi está en línea con el promedio de empresas de tamaño similar en el mercado German ($USD5.57M).

Compensación vs. Ingresos: La compensación de Kenichi ha aumentado más de un 20%, mientras que los beneficios de la empresa han caído más de un 20% en el último año.

CEO

Kenichi Hori (61 yo)

3.1yrs

Permanencia

JP¥668,000,000

Compensación

Mr. Kenichi Hori has been the President and Chief Executive Officer of Mitsui & Co., Ltd. since April 01, 2021. Mr. served as Senior Executive Managing Officer at Mitsui & Co. Ltd.since April 1, 2019 unti...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Kenichi Hori	President	3.1yrs	JP¥668.00m	0.0078% ¥ 5.4m
Tetsuya Shigeta	Senior Executive Managing Officer	2.1yrs	JP¥192.00m	0.0030% ¥ 2.1m
Yoshiaki Takemasu	Executive VP	3.1yrs	JP¥237.00m	0.0027% ¥ 1.8m
Kazumasa Nakai	Senior Executive Managing Officer & Director	no data	JP¥192.00m	0.0027% ¥ 1.9m
Toru Matsui	Senior Executive Managing Officer	4.1yrs	JP¥192.00m	0.0023% ¥ 1.6m
Makoto Sato	Senior Executive Managing Officer	2.1yrs	JP¥192.00m	0.0023% ¥ 1.6m
Motoaki Uno	Director	no data	JP¥238.00m	0.0044% ¥ 3.1m
Hideaki Konishi	General Manager of Investor Relations Division	1.1yrs	sin datos	sin datos
Yuichi Takano	Executive Managing Officer & GM of Legal Division	7.1yrs	sin datos	sin datos
Yoichiro Endo	Executive Managing Officer & COO of the Wellness Business Unit	4.1yrs	sin datos	sin datos
Sayu Ueno	Executive VP & COO of Americas Business Unit	no data	sin datos	sin datos
Yoshiki Hirabayashi	Senior Executive Managing Officer and GM of Human Resources & General Affairs Division	3.1yrs	sin datos	sin datos

3.1yrs

Permanencia media

60yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de MTS1 se considera experimentado (3 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Kenichi Hori	President	5.9yrs	JP¥668.00m	0.0078% ¥ 5.4m
Tetsuya Shigeta	Senior Executive Managing Officer	1.9yrs	JP¥192.00m	0.0030% ¥ 2.1m
Yoshiaki Takemasu	Executive VP	2.9yrs	JP¥237.00m	0.0027% ¥ 1.8m
Kazumasa Nakai	Senior Executive Managing Officer & Director	1.9yrs	JP¥192.00m	0.0027% ¥ 1.9m
Toru Matsui	Senior Executive Managing Officer	1.9yrs	JP¥192.00m	0.0023% ¥ 1.6m
Makoto Sato	Senior Executive Managing Officer	1.9yrs	JP¥192.00m	0.0023% ¥ 1.6m
Motoaki Uno	Director	2.9yrs	JP¥238.00m	0.0044% ¥ 3.1m
Tetsuya Daikoku	Director & Senior Executive managing officer	less than a year	sin datos	0.0024% ¥ 1.7m
Samuel Maurice Walsh	Independent External Director	6.9yrs	sin datos	0.00083% ¥ 576.2k
Tatsuo Yasunaga	Chairman	8.9yrs	JP¥428.00m	0.022% ¥ 15.0m
Haruhisa Iida	Associate Officer	7.1yrs	sin datos	sin datos
Kimitaka Mori	External Audit & Supervisory Board Member	6.9yrs	sin datos	0.00050% ¥ 347.1k

2.9yrs

Permanencia media

61yo

Promedio de edad

Junta con experiencia: La junta directiva de MTS1 no se considera experimentada (2.8 años de permanencia promedio), lo que sugiere una nueva junta directiva.

Mitsui Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Mitsui & Co., Ltd. Announces Change of Director

Mitsui & Co., Ltd., Annual General Meeting, Jun 19, 2024

Mitsui & Co., Ltd. Announces Management Changes

Recent updates

Full year 2024 earnings released: EPS: JP¥706 (vs JP¥722 in FY 2023)

Mitsui & Co., Ltd. (TSE:8031) announces an Equity Buyback for 40,000,000 shares, representing 2.66% for ¥200,000 million.

Rohto Pharmaceutical Co.,Ltd. (TSE:4527), Mitsui & Co., Ltd. (TSE:8031) and others agreed to acquire an 86% stake in Eu Yan Sang International Ltd from Blanca Investments Pte. Ltd., Tower Capital Asia and founding family for approximately SGD 690 million.

Mitsui & Co., Ltd. to Report Fiscal Year 2024 Results on May 01, 2024

Upcoming dividend of JP¥85.00 per share

Mitsui & Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024

Third quarter 2024 earnings released

Mitsui & Co., Ltd. Announces Change of Director

Mitsui & Co., Ltd., Annual General Meeting, Jun 19, 2024

Mitsui & Co., Ltd. to Report Q3, 2024 Results on Feb 02, 2024

RGF Staffing B.V. entered into share sale and purchase agreement to acquire additional 30% stake in RGF Staffing Delaware, Inc. from Mitsui & Co., Ltd. (TSE:8031) for approximately 130 million.

Mitsui & Co., Ltd. (TSE:8031) announces an Equity Buyback for 12,500,000 shares, representing 0.83% for ¥50,000 million.

Second quarter 2024 earnings released: EPS: JP¥135 (vs JP¥167 in 2Q 2023)

BEMAC Corporation and Mitsui & Co., Ltd. entered into a share purchase agreement to acquire 100% of the shares of The Switch Engineering Oy from YASKAWA Electric Corporation.

Mitsui & Co., Ltd. to Report First Half, 2024 Results on Oct 31, 2023

Upcoming dividend of JP¥75.00 per share at 2.6% yield

Mitsui & Co., Ltd. (TSE:8031) completed the acquisition of 49% stake in Solar Park Kassø Aps from European Energy A/S.

Mitsui & Co., Ltd. (TSE:8031) acquired 33.3% stake in Terreva Renewables, LLC from CIM Group, L.P.

CPC Reportedly Set for Dorado Stake

Mitsui & Co., Ltd. (TSE:8031) agreed to acquire Dermaceutical Laboratories Limited Liability Company.

Mitsui & Co., Ltd. to Report Q1, 2024 Final Results on Aug 09, 2023

Beacon Rail Metro Finance B.V. signed a share purchase agreement to acquire Mitsui Rail Capital Europe B.V. from Mitsui & Co., Ltd. (TSE:8031).

Yangzijiang Shipbuilding (Holdings) Ltd. (SGX:BS6) acquired additional 5% stake in Jiangsu Yangzi-Mitsui Shipbuilding Co. Ltd. from Mitsui & Co., Ltd. (TSE:8031) and Mitsui E&S Shipbuilding Co., Ltd for CNY 43.2 million.

Mitsui & Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024

First quarter 2024 earnings released: EPS: JP¥166 (vs JP¥172 in 1Q 2023)

Mitsui & Co., Ltd. (TSE:8031) executed a share purchase agreement to acquire STATS (UK) Ltd from BGF Investment Management Ltd. and others.

Mitsui & Co., Ltd. to Report Q1, 2024 Results on Aug 01, 2023

Mitsui & Co., Ltd. (TSE:8031) entered into binding agreements to acquire minority shareholder in EURICOM S.p.a. for enterprise value approximately €500 million.

Mitsui, Osaka Gas Reportedly Bid for ReNew Energy's Commercial and Industrial Project Portfolio

Full year 2023 earnings released: EPS: JP¥722 (vs JP¥562 in FY 2022)

Upcoming dividend of JP¥70.00 per share at 3.4% yield

Third quarter 2023 earnings released: EPS: JP¥194 (vs JP¥141 in 3Q 2022)

Mitsui & Co., Ltd. (TSE:8031) agreed to acquire remaining 50% stake in Aim Services Co., Ltd. from Aramark (NYSE:ARMK) for ¥70 billion.

Mitsui & Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2023

Mitsui & Co., Ltd. Announces Management Changes

Mitsui & Co., Ltd. (TSE:8031) agreed to acquire Sumitomo Pharma Animal Health Co., Ltd. from Sumitomo Pharma Co., Ltd. (TSE:4506).

Mitsui & Co., Ltd. to Report Nine Months, 2023 Results on Feb 03, 2023

CFW Partners, L.P, Mitsui & Co., Ltd. (TSE:8031), Fuyo General Lease Co., Ltd. (TSE:8424) and JA Mitsui Leasing, Ltd. submitted a non-binding proposal to acquire remaining 2.1% stake in Willis Lease Finance Corporation (NasdaqGM:WLFC) for $29.3 million.

Second quarter 2023 earnings released: EPS: JP¥167 (vs JP¥131 in 2Q 2022)

ACTIS GP LLP completed the acquisition of 40% share in MT Falcon Holdings Company S.A.P.I. de C.V. from Mitsui & Co., Ltd.

Woodside Reportedly Weighs Up Options for Scarborough

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad